1. < Home

Osteoporosis

Polypharmacy in Osteoporosis Treatment 

McConnell M, Shieh A. Polypharmacy in Osteoporosis Treatment. Clin Geriatr Med. 2022 Nov;38(4):715-726. doi: 10.1016/j.cger.2022.05.011. Epub 2022 Sep 13. PMID: 36210087.

By sjmartinez • October 12, 2022
Coronary artery calcium and bone mineral density by serial CTA: Does menopausal hormone therapy modify the association?

Cherukuri L, Kinninger A, Birudaraju D, Jayawardena E, Manubolu VS, Brinton EA, Black D, Miller V, Kearns AE, Manson JE, Budoff MJ, Roy SK. Coronary[...]

By sjmartinez • July 26, 2022
Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability-results from the Women’s Health Initiative hormone therapy trials

Lorentzon M, Johansson H, Harvey NC, Liu E, Vandenput L, Crandall CJ, Cauley JA, LeBoff MS, McCloskey EV, Kanis JA. Menopausal hormone therapy reduces the[...]

By sjmartinez • July 14, 2022
Trimethylamine N-oxide and hip fracture and bone mineral density in older adults: The cardiovascular health study

Elam RE, Bůžková P, Barzilay JI, Wang Z, Nemet I, Budoff MJ, Cauley JA, Fink HA, Lee Y, Robbins JA, Wang M, Hazen SL, Mozaffarian[...]

By rosaguerrero • May 17, 2022